Glück Conviction Score™ ⓘ
DYN
Dyne Therapeutics, Inc.
Effektiv: Risiko-Ausstieg
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
39,4
37 neu, 98 erhöht, -387439K $ netto
Aktivist
56,1
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 18.25 | -0.3 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 17.56 | +3.6 % vs SMA200 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 17.87 | EMA50: 17.94 | |
| MACD-Histogramm | Bullisch | 10 % | 0.030 | Bullisch | |
| RSI(14) | Neutral | 10 % | 52.0 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 53.4 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 12.1 | +DI: 26.9 / −DI: 21.4 | |
| Z-Score(60) | Neutral | 5 % | 0.00 | In Range | |
| 52W-Position | Neutral | 5 % | 62.1 % | Hoch 24.29 / Tief 8.18 | |
| Bollinger(20,2σ) | Neutral | 5 % | 65.7 % | Upper 19.25 / Mid 17.70 / Lower 16.16 | |
| LinReg-Slope(60) | Neutral | 10 % | -0.0146 | R²=0.08 / annualisiert -20.3 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-08 | Posner Brian S | Director | Open Market Purchase | 2.000 | 16,94 | 33.880,00 | +5,1% | |
| 2026-06-03 | Posner Brian S | Director | Open Market Purchase | 2.500 | 17,48 | 43.700,00 | +6,5% | |
| 2026-05-26 | Posner Brian S | Director | Open Market Purchase | 2.000 | 18,21 | 36.420,00 | +5,5% | |
| 2026-05-20 | Posner Brian S | Director | Open Market Purchase | 2.500 | 17,12 | 42.800,00 | +6,4% | |
| 2026-05-13 | Lucera Erick | Officer, Chief Financial Officer | Open Market Sale | -1.448 | 18,36 | -26.585,28 | -4,0% | |
| 2026-05-13 | Cox John | Director, Officer, CEO & President | Open Market Sale | -3.311 | 18,36 | -60.789,96 | -9,1% | |
| 2026-05-13 | Kerr Douglas | Officer, Chief Medical Officer | Open Market Sale | -1.564 | 18,36 | -28.715,04 | -4,3% | |
| 2026-05-13 | Friedl-Naderer Johanna | Officer, Chief Commercial Officer | Open Market Sale | -228 | 18,36 | -4.186,08 | -0,6% | |
| 2026-05-06 | Rhodes Jason P | Director | Open Market Sale | -428 | 18,18 | -7.781,04 | -1,2% | |
| 2026-05-06 | Rhodes Jason P | Director | Open Market Sale | -43.621 | 18,18 | -793.029,78 | -118,8% | |
| 2026-05-06 | Rhodes Jason P | Director | Open Market Sale | -21.926 | 18,18 | -398.614,68 | -59,7% | |
| 2026-05-06 | Rhodes Jason P | Director | Open Market Sale | -17.244 | 18,18 | -313.495,92 | -47,0% | |
| 2026-05-05 | Rhodes Jason P | Director | Open Market Sale | -2.403 | 18,03 | -43.326,09 | -6,5% | |
| 2026-05-05 | Rhodes Jason P | Director | Open Market Sale | -6.081 | 18,03 | -109.640,43 | -16,4% | |
| 2026-05-05 | Rhodes Jason P | Director | Open Market Sale | -3.056 | 18,03 | -55.099,68 | -8,3% | |
| 2026-05-05 | Rhodes Jason P | Director | Open Market Sale | -60 | 18,03 | -1.081,80 | -0,2% | |
| 2026-05-04 | Rhodes Jason P | Director | Open Market Sale | -2.466 | 18,00 | -44.388,00 | -6,6% | |
| 2026-05-04 | Rhodes Jason P | Director | Open Market Sale | -6.241 | 18,00 | -112.338,00 | -16,8% | |
| 2026-05-04 | Rhodes Jason P | Director | Open Market Sale | -3.136 | 18,00 | -56.448,00 | -8,5% | |
| 2026-05-04 | Rhodes Jason P | Director | Open Market Sale | -61 | 18,00 | -1.098,00 | -0,2% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -21 | 19,00 | -399,00 | -0,1% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -119.115 | 18,38 | -2.189.333,70 | -327,9% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -59.870 | 18,38 | -1.100.410,60 | -164,8% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -47.082 | 18,38 | -865.367,16 | -129,6% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -1.170 | 18,38 | -21.504,60 | -3,2% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -52 | 19,00 | -988,00 | -0,1% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -26 | 19,00 | -494,00 | -0,1% | |
| 2026-04-28 | Rhodes Jason P | Director | Open Market Sale | -1 | 19,00 | -19,00 | 0,0% | |
| 2026-04-27 | Rhodes Jason P | Director | Open Market Sale | -894 | 18,15 | -16.226,10 | -2,4% | |
| 2026-04-27 | Rhodes Jason P | Director | Open Market Sale | -90.943 | 18,15 | -1.650.615,45 | -247,2% | |
| 2026-04-27 | Rhodes Jason P | Director | Open Market Sale | -45.709 | 18,15 | -829.618,35 | -124,2% | |
| 2026-04-27 | Rhodes Jason P | Director | Open Market Sale | -35.947 | 18,15 | -652.438,05 | -97,7% | |
| 2026-04-24 | Rhodes Jason P | Director | Open Market Sale | -36.345 | 18,48 | -671.655,60 | -100,6% | |
| 2026-04-24 | Rhodes Jason P | Director | Open Market Sale | -710 | 18,48 | -13.120,80 | -2,0% | |
| 2026-04-24 | Rhodes Jason P | Director | Open Market Sale | -28.583 | 18,48 | -528.213,84 | -79,1% | |
| 2026-04-24 | Rhodes Jason P | Director | Open Market Sale | -72.310 | 18,48 | -1.336.288,80 | -200,1% | |
| 2026-04-23 | Rhodes Jason P | Director | Open Market Sale | -15.148 | 19,19 | -290.690,12 | -43,5% | |
| 2026-04-23 | Rhodes Jason P | Director | Open Market Sale | -38.322 | 19,19 | -735.399,18 | -110,1% | |
| 2026-04-23 | Rhodes Jason P | Director | Open Market Sale | -19.261 | 19,19 | -369.618,59 | -55,4% | |
| 2026-04-23 | Rhodes Jason P | Director | Open Market Sale | -377 | 19,19 | -7.234,63 | -1,1% | |
| 2026-04-22 | Rhodes Jason P | Director | Open Market Sale | -75.866 | 19,68 | -1.493.042,88 | -223,6% | |
| 2026-04-22 | Rhodes Jason P | Director | Open Market Sale | -150.942 | 19,68 | -2.970.538,56 | -444,9% | |
| 2026-04-22 | Kersten Dirk | Director | Open Market Sale | -2.652 | 20,00 | -53.049,28 | -7,9% | |
| 2026-04-22 | Rhodes Jason P | Director | Open Market Sale | -1.485 | 19,68 | -29.224,80 | -4,4% | |
| 2026-04-22 | Rhodes Jason P | Director | Open Market Sale | -59.663 | 19,68 | -1.174.167,84 | -175,8% | |
| 2026-04-21 | Kersten Dirk | Director | Open Market Sale | -8.300 | 20,01 | -166.120,35 | -24,9% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -15 | 20,05 | -300,75 | 0,0% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -605 | 20,05 | -12.130,25 | -1,8% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -769 | 20,05 | -15.418,45 | -2,3% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -1.398 | 19,51 | -27.274,98 | -4,1% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -1.530 | 20,05 | -30.676,50 | -4,6% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -56.228 | 19,51 | -1.097.008,28 | -164,3% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -71.499 | 19,51 | -1.394.945,49 | -208,9% | |
| 2026-04-21 | Rhodes Jason P | Director | Open Market Sale | -142.253 | 19,51 | -2.775.356,03 | -415,6% | |
| 2026-04-20 | Rhodes Jason P | Director | Open Market Sale | -142.604 | 20,06 | -2.860.636,24 | -428,4% | |
| 2026-04-20 | Rhodes Jason P | Director | Open Market Sale | -71.676 | 20,06 | -1.437.820,56 | -215,3% | |
| 2026-04-20 | Rhodes Jason P | Director | Open Market Sale | -56.368 | 20,06 | -1.130.742,08 | -169,3% | |
| 2026-04-20 | Rhodes Jason P | Director | Open Market Sale | -1.401 | 20,06 | -28.104,06 | -4,2% | |
| 2026-04-20 | Kersten Dirk | Director | Open Market Sale | -125.274 | 20,07 | -2.513.898,41 | -376,5% | |
| 2026-04-17 | Kersten Dirk | Director | Open Market Sale | -211.974 | 20,29 | -4.301.291,62 | -644,2% | |
| 2026-04-16 | Kersten Dirk | Director | Open Market Sale | -6.657 | 20,06 | -133.522,78 | -20,0% | |
| 2026-04-16 | Kersten Dirk | Director | Open Market Sale | -11.116 | 21,10 | -234.590,95 | -35,1% | |
| 2026-04-15 | Kersten Dirk | Director | Open Market Sale | -81.840 | 20,27 | -1.659.044,11 | -248,5% | |
| 2026-04-01 | Lucera Erick | Officer, Chief Financial Officer | Open Market Sale | -5.727 | 18,64 | -106.751,28 | -16,0% | |
| 2026-03-30 | Posner Brian S | Director | Open Market Purchase | 2.000 | 17,08 | 34.160,00 | +5,1% | |
| 2026-03-11 | Kersten Dirk | Director | Open Market Sale | -129.672 | 19,52 | -2.530.562,05 | -379,0% | |
| 2026-03-11 | Posner Brian S | Director | Open Market Purchase | 2.000 | 19,35 | 38.700,00 | +5,8% | |
| 2026-03-10 | Kersten Dirk | Director | Open Market Sale | -281.858 | 19,80 | -5.580.816,59 | -835,8% | |
| 2026-03-10 | Kersten Dirk | Director | Open Market Sale | -219.758 | 19,33 | -4.246.823,35 | -636,0% | |
| 2026-03-10 | Kersten Dirk | Director | Open Market Sale | -9.482 | 18,21 | -172.687,13 | -25,9% | |
| 2026-03-09 | Kersten Dirk | Director | Open Market Sale | -177.690 | 17,72 | -3.148.986,64 | -471,6% | |
| 2026-03-06 | Posner Brian S | Director | Open Market Purchase | 3.000 | 15,06 | 45.180,00 | +6,8% | |
| 2026-03-05 | Friedl-Naderer Johanna | Officer, Chief Commercial Officer | Open Market Sale | -148 | 14,90 | -2.205,20 | -0,3% | |
| 2026-03-05 | Cox John | Director, Officer, CEO & President | Open Market Sale | -2.732 | 14,90 | -40.706,80 | -6,1% | |
| 2026-03-05 | Kerr Douglas | Officer, Chief Medical Officer | Open Market Sale | -904 | 14,90 | -13.469,60 | -2,0% | |
| 2025-12-05 | Friedl-Naderer Johanna | Officer, Chief Commercial Officer | Open Market Sale | -144 | 20,72 | -2.983,68 | -0,4% | |
| 2025-12-05 | Cox John | Director, Officer, CEO & President | Open Market Sale | -2.662 | 20,72 | -55.156,64 | -8,3% | |
| 2025-12-05 | Kerr Douglas | Officer, Chief Medical Officer | Open Market Sale | -880 | 20,72 | -18.233,60 | -2,7% | |
| 2025-09-05 | Friedl-Naderer Johanna | Officer, Chief Commercial Officer | Open Market Sale | -144 | 13,41 | -1.931,04 | -0,3% | |
| 2025-09-05 | Cox John | Director, Officer, CEO & President | Open Market Sale | -2.640 | 13,41 | -35.402,40 | -5,3% | |
| 2025-09-05 | Kerr Douglas | Officer, Chief Medical Officer | Open Market Sale | -873 | 13,41 | -11.706,93 | -1,8% | |
| 2025-09-04 | Kerr Douglas | Officer, Chief Medical Officer | Open Market Sale | -3.552 | 13,27 | -47.135,04 | -7,1% | |
| 2025-09-04 | Friedl-Naderer Johanna | Officer, Chief Commercial Officer | Open Market Sale | -894 | 13,27 | -11.863,38 | -1,8% | |
| 2025-07-14 | Cox John | Director, Officer, CEO & President | Open Market Purchase | 100.000 | 9,11 | 911.000,00 | +136,4% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 13.647.376 | 13.887.722 | -240.346 | 247.426.927 | Reduziert | -1,7% | |
| VANGUARD GROUP INC | 11.215.565 | 0 | 11.215.565 | 219.376.451 | Neu | +100,0% | |
| BlackRock, Inc. | 11.699.870 | 11.190.838 | 509.032 | 212.118.644 | Aufgestockt | +4,5% | |
| Atlas Venture Life Science Advisors, LLC | 9.130.465 | 9.130.465 | 0 | 165.535.330 | Unverändert | 0,0% | |
| FMR LLC | 8.908.980 | 6.569.921 | 2.339.059 | 161.519.805 | Aufgestockt | +35,6% | |
| Orbis Allan Gray Ltd | 6.762.231 | 4.801.928 | 1.960.303 | 122.599.248 | Aufgestockt | +40,8% | |
| STATE STREET CORP | 6.653.746 | 6.692.745 | -38.999 | 120.632.415 | Reduziert | -0,6% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.405.069 | 0 | 6.405.069 | 116.123.901 | Neu | +100,0% | |
| PERCEPTIVE ADVISORS LLC | 4.668.839 | 3.478.944 | 1.189.895 | 84.646.051 | Aufgestockt | +34,2% | |
| FCPM III SERVICES B.V. | 4.644.386 | 5.462.846 | -818.460 | 84.202.718 | Reduziert | -15,0% | |
| TCG Crossover Management, LLC | 4.615.144 | 4.615.144 | 0 | 83.672.561 | Unverändert | 0,0% | |
| Vestal Point Capital, LP | 4.000.000 | 120.000 | 3.880.000 | 72.520.000 | Aufgestockt | +3233,3% | |
| JPMORGAN CHASE & CO | 3.549.909 | 0 | 3.549.909 | 69.436.220 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 3.504.114 | 3.263.429 | 240.685 | 63.542.557 | Aufgestockt | +7,4% | |
| ARMISTICE CAPITAL, LLC | 3.175.110 | 3.249.708 | -74.598 | 57.564.744 | Reduziert | -2,3% | |
| Frazier Life Sciences Management, L.P. | 3.153.082 | 3.153.082 | 0 | 57.165.377 | Unverändert | 0,0% | |
| ORBIMED ADVISORS LLC | 2.917.884 | 2.202.184 | 715.700 | 52.901.237 | Aufgestockt | +32,5% | |
| Siren, L.L.C. | 2.229.125 | 3.502.941 | -1.273.816 | 40.414.036 | Reduziert | -36,4% | |
| Venrock Adviser, LLC | 2.173.913 | 2.173.913 | 0 | 39.413.043 | Unverändert | 0,0% | |
| FRANKLIN RESOURCES INC | 2.009.082 | 2.006.638 | 2.444 | 36.424.648 | Aufgestockt | +0,1% | |
| Deep Track Capital, LP | 2.000.000 | 2.650.000 | -650.000 | 36.260.000 | Reduziert | -24,5% | |
| SAMLYN CAPITAL, LLC | 1.922.543 | 1.493.075 | 429.468 | 34.855.705 | Aufgestockt | +28,8% | |
| GOLDMAN SACHS GROUP INC | 1.723.116 | 2.283.191 | -560.075 | 31.240.093 | Reduziert | -24,5% | |
| BRAIDWELL LP | 1.681.998 | 1.478.329 | 203.669 | 30.494.624 | Aufgestockt | +13,8% | |
| Palo Alto Investors LP | 1.652.972 | 1.472.197 | 180.775 | 29.968.382 | Aufgestockt | +12,3% | |
| Sofinnova Investments, Inc. | 1.633.897 | 2.254.161 | -620.264 | 29.622.553 | Reduziert | -27,5% | |
| Vivo Capital, LLC | 1.557.466 | 2.614.960 | -1.057.494 | 28.236.859 | Reduziert | -40,4% | |
| BANK OF AMERICA CORP /DE/ | 1.443.313 | 882.922 | 560.391 | 26.167.264 | Aufgestockt | +63,5% | |
| Aberdeen Group plc | 1.430.384 | 1.108.145 | 322.239 | 25.932.862 | Aufgestockt | +29,1% | |
| MPM BioImpact LLC | 1.408.152 | 1.405.388 | 2.764 | 25.529.796 | Aufgestockt | +0,2% | |
| Logos Global Management LP | 1.400.000 | 1.250.000 | 150.000 | 25.382.000 | Aufgestockt | +12,0% | |
| Fiera Capital Corp | 1.380.620 | 0 | 1.380.620 | 25.030.641 | Neu | +100,0% | |
| Polar Capital Holdings Plc | 1.359.169 | 1.269.131 | 90.038 | 24.641.734 | Aufgestockt | +7,1% | |
| NORTHERN TRUST CORP | 1.198.838 | 1.092.191 | 106.647 | 21.734.932 | Aufgestockt | +9,8% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.158.390 | 1.151.325 | 7.065 | 21.001.611 | Aufgestockt | +0,6% | |
| Candriam S.C.A. | 1.057.263 | 0 | 1.057.263 | 20.680.945 | Neu | +100,0% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.000.000 | 5.172.000 | -4.172.000 | 18.130.000 | Reduziert | -80,7% | |
| Rock Springs Capital Management LP | 972.198 | 912.955 | 59.243 | 17.625.950 | Aufgestockt | +6,5% | |
| Saturn V Capital Management LP | 966.609 | 1.788.616 | -822.007 | 17.524.621 | Reduziert | -46,0% | |
| DIMENSIONAL FUND ADVISORS LP | 951.589 | 98.074 | 853.515 | 17.244.372 | Aufgestockt | +870,3% | |
| MORGAN STANLEY | 929.003 | 1.213.559 | -284.556 | 16.842.827 | Reduziert | -23,4% | |
| Squarepoint Ops LLC | 834.176 | 255.160 | 579.016 | 15.123.611 | Aufgestockt | +226,9% | |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 821.849 | 1.138.868 | -317.019 | 14.900.122 | Reduziert | -27,8% | |
| BAKER BROS. ADVISORS LP | 813.449 | 813.449 | 0 | 14.747.830 | Unverändert | 0,0% | |
| EVENTIDE ASSET MANAGEMENT, LLC | 680.305 | 0 | 680.305 | 13.306.369 | Neu | +100,0% | |
| Nuveen, LLC | 718.333 | 621.310 | 97.023 | 13.023.378 | Aufgestockt | +15,6% | |
| ArrowMark Colorado Holdings LLC | 673.949 | 700.653 | -26.704 | 12.218.695 | Reduziert | -3,8% | |
| Artisan Partners Limited Partnership | 619.457 | 649.691 | -30.234 | 11.230.755 | Reduziert | -4,7% | |
| RENAISSANCE TECHNOLOGIES LLC | 533.600 | 470.645 | 62.955 | 9.674.168 | Aufgestockt | +13,4% | |
| TD ASSET MANAGEMENT INC | 529.312 | 419.756 | 109.556 | 9.596.427 | Aufgestockt | +26,1% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 13.647.376 | 13.887.722 | -1,7% | 247.426.927 | 9,19 |
| BlackRock, Inc. | 11.699.870 | 11.190.838 | +4,5% | 212.118.644 | 7,88 |
| Atlas Venture Life Science Advisors, LLC | 9.130.465 | 9.130.465 | 0,0% | 165.535.330 | 6,15 |
| FMR LLC | 8.908.980 | 6.569.921 | +35,6% | 161.519.805 | 6,00 |
| Orbis Allan Gray Ltd | 6.762.231 | 4.801.928 | +40,8% | 122.599.248 | 4,55 |
| STATE STREET CORP | 6.653.746 | 6.692.745 | -0,6% | 120.632.415 | 4,48 |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.405.069 | 0 | +100,0% | 116.123.901 | 4,31 |
| PERCEPTIVE ADVISORS LLC | 4.668.839 | 3.478.944 | +34,2% | 84.646.051 | 3,14 |
| FCPM III SERVICES B.V. | 4.644.386 | 5.462.846 | -15,0% | 84.202.718 | 3,13 |
| TCG Crossover Management, LLC | 4.615.144 | 4.615.144 | 0,0% | 83.672.561 | 3,11 |
| Vestal Point Capital, LP | 4.000.000 | 120.000 | +3233,3% | 72.520.000 | 2,69 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.504.114 | 3.263.429 | +7,4% | 63.542.557 | 2,36 |
| ARMISTICE CAPITAL, LLC | 3.175.110 | 3.249.708 | -2,3% | 57.564.744 | 2,14 |
| Frazier Life Sciences Management, L.P. | 3.153.082 | 3.153.082 | 0,0% | 57.165.377 | 2,12 |
| JPMORGAN CHASE & CO | 3.253.473 | 3.549.909 | -8,4% | 55.601.855 | 2,06 |
| ORBIMED ADVISORS LLC | 2.917.884 | 2.202.184 | +32,5% | 52.901.237 | 1,96 |
| Siren, L.L.C. | 2.229.125 | 3.502.941 | -36,4% | 40.414.036 | 1,50 |
| Venrock Adviser, LLC | 2.173.913 | 2.173.913 | 0,0% | 39.413.043 | 1,46 |
| FRANKLIN RESOURCES INC | 2.009.082 | 2.006.638 | +0,1% | 36.424.648 | 1,35 |
| Deep Track Capital, LP | 2.000.000 | 2.650.000 | -24,5% | 36.260.000 | 1,35 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 226 | 214,7 | 3.277 |
| 31.12.2025 | ✓ | 231 | 185,9 | 3.175 |
| 30.09.2025 | ✓ | 206 | 162,3 | 1.996 |
| 30.06.2025 | ✓ | 194 | 130,1 | 1.185 |
| 31.03.2025 | ✓ | 201 | 132,2 | 1.347 |
| 31.12.2024 | ✓ | 200 | 115,6 | 2.655 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| Orbis Allan Gray Ltd | 4.801.928 | 93.925.712 |
| SAMLYN CAPITAL, LLC | 1.493.075 | 29.204.548 |
| BAKER BROS. ADVISORS LP | 813.449 | 15.911.062 |
| EVENTIDE ASSET MANAGEMENT, LLC | 680.305 | 13.306.369 |
| Artisan Partners Limited Partnership | 649.691 | 12.707.956 |
| Catalio Capital Management, LP | 519.715 | 10.165.625 |
| FEDERATED HERMES, INC. | 464.797 | 9.091.429 |
| BALYASNY ASSET MANAGEMENT L.P. | 432.986 | 8.469.206 |
| Clearbridge Investments, LLC | 407.794 | 7.976.444 |
| Y-Intercept (Hong Kong) Ltd | 343.726 | 6.723.281 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 17.540.089 | 14.727.667 | +523.7 % | 343.085 |
| PERCEPTIVE ADVISORS LLC | 3.478.944 | 2.938.500 | +543.7 % | 68.048.145 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.172.000 | 1.618.000 | +45.5 % | 101.164.320 |
| BlackRock, Inc. | 11.190.838 | 1.555.929 | +16.1 % | 218.892.793 |
| VANGUARD GROUP INC | 11.215.565 | 1.455.151 | +14.9 % | 219.376.451 |
| STATE STREET CORP | 6.692.745 | 1.423.828 | +27.0 % | 130.910.092 |
| Sofinnova Investments, Inc. | 2.254.161 | 1.268.333 | +128.7 % | 44.091.389 |
| FMR LLC | 6.569.921 | 1.168.005 | +21.6 % | 128.507.653 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.323.789 | 925.702 | +66.2 % | 45.454 |
| Polar Capital Holdings Plc | 1.269.131 | 739.743 | +139.7 % | 24.824.202 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Vestal Point Capital, LP | 120.000 | -2.655.000 | -95.7 % | 2.347.200 |
| MARSHALL WACE, LLP | 676.979 | -2.336.398 | -77.5 % | 13.241.709 |
| CITADEL ADVISORS LLC | 1.227.224 | -2.230.811 | -64.5 % | 24.004.502 |
| Point72 Asset Management, L.P. | 329.345 | -1.388.462 | -80.8 % | 6.441.988 |
| BRAIDWELL LP | 1.478.329 | -1.252.152 | -45.9 % | 28.916.115 |
| Siren, L.L.C. | 3.502.941 | -1.226.233 | -25.9 % | 68.517.526 |
| Logos Global Management LP | 1.250.000 | -1.150.000 | -47.9 % | 24.450.000 |
| Saturn V Capital Management LP | 1.788.616 | -885.853 | -33.1 % | 34.985.329 |
| JANUS HENDERSON GROUP PLC | 13.887.722 | -857.783 | -5.8 % | 271.603.659 |
| ROYAL BANK OF CANADA | 18.547 | -524.619 | -96.6 % | 363.000 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 15.05.2026 | T. Rowe Price Investment Management, Inc. | Passiv (13G/A) | 18,70 % | 30.785.801 | +2,50 pp | |
| 15.05.2026 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 8,30 % | 13.647.376 | -0,20 pp | |
| 06.05.2026 | FMR LLC | Passiv (13G) | 5,40 % | 8.908.980 | +0,80 pp | |
| 06.05.2026 | Abigail P. Johnson | Passiv (13G) | 5,40 % | 8.908.980 | +0,80 pp | |
| 26.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -6,83 pp | |
| 06.03.2026 | T. Rowe Price Investment Management, Inc. | Passiv (13G/A) | 16,20 % | 26.578.437 | +5,50 pp | |
| 17.02.2026 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 8,50 % | 13.887.722 | -1,90 pp | |
| 08.01.2026 | T. Rowe Price Investment Management, Inc. | Passiv (13G) | 10,70 % | 17.540.089 | Neu | |
| 14.11.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 10,40 % | 14.745.505 | +0,30 pp | |
| 14.11.2025 | RA Capital Healthcare Fund, L.P. | Passiv (13G/A) | Ausstieg | 0 | -8,50 pp | |
| 14.11.2025 | Rajeev Shah | Passiv (13G/A) | Ausstieg | 0 | -8,50 pp | |
| 14.11.2025 | Peter Kolchinsky | Passiv (13G/A) | Ausstieg | 0 | -8,50 pp | |
| 14.11.2025 | RA Capital Management, L.P. | Passiv (13G/A) | Ausstieg | 0 | -8,50 pp | |
| 13.11.2025 | Atlas Venture Associates XI, LLC | Passiv (13G/A) | 4,00 % | 5.713.470 | -1,70 pp | |
| 13.11.2025 | Atlas Venture Associates Opportunity II, LLC | Passiv (13G/A) | 1,40 % | 1.958.427 | -0,40 pp | |
| 13.11.2025 | Atlas Venture Associates Opportunity I, L.P. | Passiv (13G/A) | 1,00 % | 1.458.568 | -0,50 pp | |
| 13.11.2025 | Atlas Venture Opportunity Fund I, L.P. | Passiv (13G/A) | 1,00 % | 1.458.568 | -0,50 pp | |
| 13.11.2025 | Atlas Venture Associates Opportunity I, LLC | Passiv (13G/A) | 1,00 % | 1.458.568 | -0,50 pp | |
| 13.11.2025 | Atlas Venture Opportunity Fund II, L.P. | Passiv (13G/A) | 1,40 % | 1.958.427 | +0,60 pp | |
| 13.11.2025 | Atlas Venture Associates XI, L.P. | Passiv (13G/A) | 4,00 % | 5.713.470 | -1,70 pp | |
| 13.11.2025 | Atlas Venture Fund XI, L.P. | Passiv (13G/A) | 4,00 % | 5.697.508 | -1,70 pp | |
| 13.11.2025 | Atlas Venture Associates Opportunity II, LP | Passiv (13G/A) | 1,40 % | 1.958.427 | Neu | |
| 07.08.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 10,10 % | 14.394.999 | +0,90 pp | |
| 15.05.2025 | Rajeev Shah | Passiv (13G/A) | 8,50 % | 9.714.392 | +2,10 pp | |
| 15.05.2025 | RA Capital Management, L.P. | Passiv (13G/A) | 8,50 % | 9.714.392 | +2,10 pp | |
| 15.05.2025 | Peter Kolchinsky | Passiv (13G/A) | 8,50 % | 9.714.392 | +2,10 pp | |
| 15.05.2025 | RA Capital Healthcare Fund, L.P. | Passiv (13G/A) | 8,50 % | 9.714.392 | +2,10 pp | |
| 15.05.2025 | Forbion Growth Opportunities Fund II Cooperatief U.A. | Passiv (13G/A) | 1,30 % | 1.426.370 | Neu | |
| 15.05.2025 | Forbion IV Management B.V. | Passiv (13G/A) | 3,60 % | 4.036.476 | Neu | |
| 15.05.2025 | ForDyne B.V. | Passiv (13G/A) | 4,80 % | 5.400.545 | Neu | |
| 15.05.2025 | Forbion Capital Fund IV Cooperatief U.A. | Passiv (13G/A) | 3,60 % | 4.036.476 | Neu | |
| 15.05.2025 | Forbion Growth II Management B.V. | Passiv (13G/A) | 1,30 % | 1.426.370 | Neu | |
| 15.05.2025 | Roderick Wong, M.D. | Passiv (13G/A) | 1,50 % | 1.690.567 | -3,60 pp | |
| 15.05.2025 | RTW Investments, LP | Passiv (13G/A) | 1,50 % | 1.690.567 | -3,60 pp | |
| 15.05.2025 | Point72 Capital Advisors, Inc. | Passiv (13G/A) | 1,50 % | 1.669.342 | -3,60 pp | |
| 15.05.2025 | Steven A. Cohen | Passiv (13G/A) | 1,50 % | 1.669.342 | -3,60 pp | |
| 15.05.2025 | Point72 Asset Management, L.P. | Passiv (13G/A) | 1,50 % | 1.669.342 | -3,60 pp | |
| 14.05.2025 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 9,20 % | 10.353.875 | +1,90 pp | |
| 12.05.2025 | FMR LLC | Passiv (13G/A) | 4,60 % | 5.195.294 | -3,30 pp | |
| 12.05.2025 | Abigail P. Johnson | Passiv (13G/A) | 4,60 % | 5.195.294 | -3,30 pp |
Stammdaten
Dyne Therapeutics, Inc., ein Unternehmen im Bereich Muskelerkrankungen, operiert als Biotechnologie-Unternehmen, das sich auf die Entwicklung von Therapeutika für genetisch bedingte Muskelerkrankungen in den Vereinigten Staaten konzentriert. Es entwickelt verschiedene Programme für myotone Dystrophie Typ 1, Duchenne-Muskeldystrophie und fazioscapulohumeale Dystrophie sowie seltene Skelettmuskel-, Herz- und metabolische Muskelerkrankungen unter Verwendung seiner FORCE-Plattform, die krankheitsmodifizierende Therapeutika bereitstellt. Das Unternehmen wurde 2017 gegründet und hat seinen Hauptsitz in Waltham, Massachusetts.
Unternehmen & Branche
| Name | Dyne Therapeutics, Inc. |
|---|---|
| Ticker | DYN |
| CIK | 0001818794 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 26818M108 |
|---|---|
| ISIN | US26818M1080 |
| Typ | Common Stock |
| Marktkapitalisierung | 2,96 Mrd. USD |
| Beta | 1,09 |
Bewertung
| KBV (P/B) | 3,05 vs. 1,67 (2021) ▲ |
|---|---|
| FCF-Rendite | -13,7 % vs. -20,1 % (2021) ▲ |
Qualität & Bilanz
| ROIC | -39,1 % vs. -37,2 % (2021) ▼ |
|---|
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 1,67 | 2,56 | 8,96 | 3,83 | 3,32 | |
| FCF-Rendite | -20,1 % | -24,3 % | -23,1 % | -12,2 % | -12,6 % | |
| Qualität & Bilanz | ||||||
| ROIC | -37,2 % | -59,4 % | -198,8 % | -48,5 % | -39,1 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | -120.854.000 | -0,73 | 1.079.950.000 | 865.055.000 | |
| 2025-12-31 | 10-K | -446.214.000 | -3,47 | 1.186.958.000 | 972.129.000 | |
| 2025-09-30 | 10-Q | -108.041.000 | -0,76 | 867.059.000 | 691.783.000 | |
| 2025-06-30 | 10-Q | -110.857.000 | -0,97 | 728.992.000 | 571.445.000 | |
| 2025-03-31 | 10-Q | -115.361.000 | -1,05 | 721.074.000 | 668.973.000 | |
| 2024-12-31 | 10-K | -317.418.000 | -3,37 | 691.234.000 | 629.838.000 | |
| 2024-09-30 | 10-Q | -97.125.000 | -0,96 | 768.844.000 | 705.540.000 | |
| 2024-06-30 | 10-Q | -65.102.000 | -0,70 | 825.884.000 | 775.193.000 | |
| 2024-03-31 | 10-Q | -65.649.000 | -0,81 | 522.279.000 | 478.055.000 | |
| 2023-12-31 | 10-K | -235.937.000 | -3,95 | 165.082.000 | 91.292.000 | |
| 2023-09-30 | 10-Q | -60.210.000 | -0,99 | 205.244.000 | 152.038.000 | |
| 2023-06-30 | 10-Q | -64.902.000 | -1,08 | 251.421.000 | 206.877.000 | |
| 2023-03-31 | 10-Q | -44.187.000 | -0,78 | 288.642.000 | 241.935.000 | |
| 2022-12-31 | 10-K | -168.099.000 | -3,23 | 306.325.000 | 252.364.000 | |
| 2022-09-30 | 10-Q | -41.385.000 | -0,80 | 299.679.000 | 249.744.000 | |
| 2022-06-30 | 10-Q | -52.304.000 | -1,01 | 340.026.000 | 287.059.000 | |
| 2022-03-31 | 10-Q | -35.583.000 | -0,69 | 387.762.000 | 336.459.000 | |
| 2021-12-31 | 10-K | -149.291.000 | -2,93 | 425.663.000 | 368.197.000 | |
| 2021-09-30 | 10-Q | -42.582.000 | -0,83 | 466.878.000 | 414.116.000 | |
| 2021-06-30 | 10-Q | -29.955.000 | -0,58 | 467.147.000 | 452.596.000 |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 11.05.2026 | – | -0,73 |
| Q3 2025 | 30.09.2025 | 05.11.2025 | – | -0,76 |
| Q2 2025 | 30.06.2025 | 05.11.2025 | – | -0,97 |
| Q1 2025 | 31.03.2025 | 11.05.2026 | – | -1,05 |
| Q3 2024 | 30.09.2024 | 05.11.2025 | – | -0,96 |
| Q2 2024 | 30.06.2024 | 05.11.2025 | – | -0,70 |
| Q1 2024 | 31.03.2024 | 05.11.2025 | – | -0,81 |
| Q3 2023 | 30.09.2023 | 12.11.2024 | – | -0,99 |
| Q2 2023 | 30.06.2023 | 12.11.2024 | – | -1,08 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 11.05.2026 | 10-Q | – | – | SEC » |
| 02.03.2026 | 10-K | 31.12.2025 | 61 Tage | SEC » |
| 05.11.2025 | 10-Q | 30.09.2025 | 36 Tage | SEC » |
| 28.07.2025 | 10-Q | 30.06.2025 | 28 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 27.02.2025 | 10-K | 31.12.2024 | 58 Tage | SEC » |
| 12.11.2024 | 10-Q | 30.09.2024 | 43 Tage | SEC » |
| 12.08.2024 | 10-Q | 30.06.2024 | 43 Tage | SEC » |
| 02.05.2024 | 10-Q | 31.03.2024 | 32 Tage | SEC » |
| 05.03.2024 | 10-K | 31.12.2023 | 65 Tage | SEC » |
| 30.10.2023 | 10-Q | 30.09.2023 | 30 Tage | SEC » |
| 03.08.2023 | 10-Q | 30.06.2023 | 34 Tage | SEC » |
| 11.05.2023 | 10-Q | 31.03.2023 | 41 Tage | SEC » |
| 02.03.2023 | 10-K | 31.12.2022 | 61 Tage | SEC » |
| 03.11.2022 | 10-Q | 30.09.2022 | 34 Tage | SEC » |
| 04.08.2022 | 10-Q | 30.06.2022 | 35 Tage | SEC » |
| 02.05.2022 | 10-Q | 31.03.2022 | 32 Tage | SEC » |
| 10.03.2022 | 10-K | 31.12.2021 | 69 Tage | SEC » |
| 04.11.2021 | 10-Q | 30.09.2021 | 35 Tage | SEC » |
| 05.08.2021 | 10-Q | 30.06.2021 | 36 Tage | SEC » |
| 06.05.2021 | 10-Q | 31.03.2021 | 36 Tage | SEC » |
| 04.03.2021 | 10-K | 31.12.2020 | 63 Tage | SEC » |
| 05.11.2020 | 10-Q | 30.09.2020 | 36 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 23.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 02.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 25.05.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 03.03.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-12 | 3.497 | 18,46 | 64.555 |
| 2026-05-11 | 1 | 17,61 | 18 |
| 2026-05-07 | 5 | 18,84 | 94 |
| 2026-04-22 | 2.264 | 19,21 | 43.491 |
| 2026-04-20 | 41.278 | 20,41 | 842.484 |
| 2026-04-02 | 3.836 | 18,10 | 69.432 |
| 2026-03-27 | 14.086 | 18,55 | 261.295 |
| 2026-03-25 | 51.519 | 17,85 | 919.614 |
| 2026-03-12 | 848 | 19,99 | 16.952 |
| 2026-03-11 | 285.203 | 19,78 | 5.641.315 |
| 2026-03-06 | 53.575 | 15,20 | 814.340 |
| 2026-03-04 | 255 | 14,60 | 3.723 |
| 2026-02-13 | 28 | 16,00 | 448 |
| 2026-02-12 | 1.105 | 16,68 | 18.431 |
| 2026-02-11 | 295 | 17,14 | 5.056 |
| 2026-02-04 | 12.549 | 18,96 | 237.929 |
| 2026-01-20 | 600 | 16,71 | 10.026 |
| 2026-01-07 | 2.526 | 18,12 | 45.771 |
| 2025-12-30 | 190.053 | 19,59 | 3.723.138 |
| 2025-12-22 | 3.061 | 19,85 | 60.761 |
| 2025-12-19 | 5.000 | 18,55 | 92.750 |
| 2025-12-16 | 35.000 | 19,59 | 685.650 |